Literature DB >> 15145953

Proteolytic conversion of STAT3alpha to STAT3gamma in human neutrophils: role of granule-derived serine proteases.

Takayuki Kato1, Erina Sakamoto, Haruo Kutsuna, Akiko Kimura-Eto, Fumihiko Hato, Seiichi Kitagawa.   

Abstract

Four isoforms (alpha, beta, gamma, and delta) have been identified for signal transducer and activator of transcription 3 (STAT3). It has been reported that STAT3gamma, which is derived from STAT3alpha by limited proteolysis during granulocytic differentiation, is a major STAT3 isoform expressed in human neutrophils. We confirmed that STAT3gamma was a major STAT3 isoform detected in human neutrophil lysates prepared with the conventional lysis buffer. The enzymes capable of converting STAT3alpha to STAT3gamma in vitro were localized in neutrophil granule fraction and were released into the medium upon ionomycin stimulation. The enzyme activity was strongly inhibited by phenylmethylsulfonyl fluoride, CuSO(4), and ONO-5046 (a specific inhibitor of neutrophil elastase), but not by aprotinin, leupeptin, benzamidine, and EDTA. STAT3gamma was effectively generated in vitro from STAT3alpha by limited proteolysis with human neutrophil elastase or proteinase 3 but not cathepsin G. The converting activity in neutrophil lysates was reduced by immunodepletion of elastase but not proteinase 3. Unexpectedly, STAT3gamma was undetected in the lysates of neutrophil-derived cytoplasts, which lack granules, and the cytosol fraction prepared by nitrogen cavitation. The STAT3 isoform detected in these preparations was primarily STAT3alpha. STAT3gamma was also undetected in the lysates of PMSF-pretreated neutrophils and was markedly decreased in the lysates of ionomycin-pretreated neutrophils. These findings indicate that, in contrast to the previous reports, STAT3alpha, but not STAT3gamma, is primarily expressed in human neutrophils, and STAT3gamma is rapidly generated from STAT3alpha by limited proteolysis with granule-derived serine proteases during preparation of neutrophil lysates with the conventional lysis buffer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15145953     DOI: 10.1074/jbc.M400637200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Regulation of neutrophil functions by proinflammatory cytokines.

Authors:  Takayuki Kato; Seiichi Kitagawa
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

Review 2.  IL-32, a novel cytokine with a possible role in disease.

Authors:  C A Dinarello; S-H Kim
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

3.  FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report.

Authors:  Michele S Redell; Marcos J Ruiz; Robert B Gerbing; Todd A Alonzo; Beverly J Lange; David J Tweardy; Soheil Meshinchi
Journal:  Blood       Date:  2012-12-14       Impact factor: 22.113

4.  Proteinase 3 is an IL-32 binding protein.

Authors:  Daniela Novick; Menachem Rubinstein; Tania Azam; Aharon Rabinkov; Charles A Dinarello; Soo-Hyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-17       Impact factor: 11.205

5.  Toll-like receptor agonists stimulate human neutrophil migration via activation of mitogen-activated protein kinases.

Authors:  Kazuki Aomatsu; Takayuki Kato; Hisakazu Fujita; Fumihiko Hato; Nobuhide Oshitani; Noriko Kamata; Tomohiko Tamura; Tetsuo Arakawa; Seiichi Kitagawa
Journal:  Immunology       Date:  2007-07-28       Impact factor: 7.397

Review 6.  Signal transducer and activator of transcription 3 signaling as a potential target to treat muscle wasting diseases.

Authors:  David Sala; Alessandra Sacco
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2016-05       Impact factor: 4.294

7.  Purification and identification of the STAT5 protease in myeloid cells.

Authors:  Björn Schuster; Lisa Hendry; Helen Byers; Steven F Lynham; Malcolm A Ward; Susan John
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

8.  Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; T Kris Eckols; Mikhail Kolosov; Paul Lang; Kurt Christensen; Dean P Edwards; David J Tweardy
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

9.  Chemical probes that competitively and selectively inhibit Stat3 activation.

Authors:  Xuejun Xu; Moses M Kasembeli; Xueqing Jiang; Benjamin J Tweardy; David J Tweardy
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

Review 10.  The role of STAT3 in autophagy.

Authors:  Liangkun You; Zhanggui Wang; Hongsen Li; Jiawei Shou; Zhao Jing; Jiansheng Xie; Xinbing Sui; Hongming Pan; Weidong Han
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.